Regulations.gov document
Suitability Petition from Reyoung Pharmaceutical Co., Ltd.
Other · FDA-2023-P-5675 · posted Dec 26, 2023
Key facts
| Document ID | FDA-2023-P-5675-0001 |
|---|---|
| Title | Suitability Petition from Reyoung Pharmaceutical Co., Ltd. |
| Document type | Other |
| Subtype | Petition(s) |
| Agency | FDA |
| Docket | FDA-2023-P-5675 |
| Posted | Dec 26, 2023 |
| Comment period opens | Dec 26, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: